Help propel research forward, no matter what.

• The Society will continue to fund researchers so they can achieve their critical project milestones.

• The newly launched COViMS registry will provide vital data to help researchers learn whether MS or its treatments affect the outcomes of COVID-19.

• Our work to advance a global consensus on the most promising pathways to an MS cure continues.

Don’t miss this chance to personally advance MS research — more progress is possible, but only with YOUR support. Give today and 100% of your donation will go directly to research.